Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib in untreated high-grade serous ovarian cancer
NCT02470585Phase 3Terminated
- Sponsor
- AbbVie Inc.
- Start
- Jul 2015
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of veliparib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by AbbVie Inc.. Started Jul 2015; status: terminated.
02
Drugs
veliparib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT02470585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02470585.